Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
The 2027-2032 World Outlook for Efficacy Testing Consumables
US$ 1,195.00
This study covers the world outlook for efficacy testing consumables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Empty Drug Capsules
US$ 1,195.00
This study covers the world outlook for empty drug capsules across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Empty Gelatin Capsules
US$ 1,195.00
This study covers the world outlook for empty gelatin capsules across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Enteral Antibacterial Drugs
US$ 1,195.00
This study covers the world outlook for enteral antibacterial drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
287 pages
The 2027-2032 World Outlook for Enteric Soft Gel Capsules
US$ 1,195.00
This study covers the world outlook for enteric soft gel capsules across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Enzyme Replacement Therapies
US$ 1,195.00
This study covers the world outlook for enzyme replacement therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for ePharmacies
US$ 1,195.00
This study covers the world outlook for ePharmacies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
288 pages
The 2027-2032 World Outlook for Epilepsy Therapeutics
US$ 1,195.00
This study covers the world outlook for epilepsy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Epinephrine Auto-Injectors
US$ 1,195.00
This study covers the world outlook for epinephrine auto-injectors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
The 2027-2032 World Outlook for Epoetin-Alfa
US$ 1,195.00
This study covers the world outlook for epoetin-Alfa across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Erythropoietin Drugs
US$ 1,195.00
This study covers the world outlook for erythropoietin drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Fabry Disease Treatments
US$ 1,195.00
This study covers the world outlook for Fabry disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Fill Finish Manufacturing
US$ 1,195.00
This study covers the world outlook for fill finish manufacturing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Flu Treatments
US$ 1,195.00
This study covers the world outlook for flu treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Flu Vaccines
US$ 1,195.00
This study covers the world outlook for flu vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Foot Care Medicines
US$ 1,195.00
This study covers the world outlook for foot care medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Gastroparesis Drugs
US$ 1,195.00
This study covers the world outlook for gastroparesis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Gaucher Disease Treatments
US$ 1,195.00
This study covers the world outlook for gaucher disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for Genital Herpes Treatments
US$ 1,195.00
This study covers the world outlook for genital herpes treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Genitourinary Drugs
US$ 1,195.00
This study covers the world outlook for genitourinary drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Germcitabine HCI
US$ 1,195.00
This study covers the world outlook for germcitabine HCI across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Gonorrhea Therapeutics
US$ 1,195.00
This study covers the world outlook for gonorrhea therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Gout Therapeutics
US$ 1,195.00
This study covers the world outlook for gout therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Gynecology Drugs
US$ 1,195.00
This study covers the world outlook for gynecology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for H1N1 2009 Influenza Vaccines
US$ 1,195.00
This study covers the world outlook for H1N1 2009 influenza vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for H1N1 (Swine Flu) Vaccination
US$ 1,195.00
This study covers the world outlook for H1N1 (swine flu) vaccination across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Healthcare CRO Services
US$ 1,195.00
This study covers the world outlook for healthcare CRO services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Healthcare Distribution
US$ 1,195.00
This study covers the world outlook for healthcare distribution across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
288 pages
